Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mira Pharmaceuticals Inc (MIRA)

Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mira Pharmaceuticals Inc 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33606 USA

https://mirapharmaceuticals.com Employees: 3 P: 786-432-9792

Description:

MIRA Pharmaceuticals Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. MIRA Pharmaceuticals Inc. is based in Baltimore, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 20,867
Enterprise Value, $K 16,267
Shares Outstanding, K 16,561
Annual Sales, $ 0 K
Annual Net Income, $ -11,980 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,040 K
EBIT, $ -8,180 K
EBITDA, $ -7,450 K
60-Month Beta 3.09
% of Insider Shareholders 6.65%
% of Institutional Shareholders 35.16%
Float, K 15,460
% Float 93.35%
Short Volume Ratio 0.57

Growth:

1-Year Return -58.69%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -0.56
EPS Growth vs. Prev Qtr -27.27%
EPS Growth vs. Prev Year 46.15%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MIRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -337.44%
Return-on-Assets % -280.58%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.23
Book Value/Share 0.24
Interest Coverage -2.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar